CN112708660B - Crispr-poct检测组合物及其应用 - Google Patents
Crispr-poct检测组合物及其应用 Download PDFInfo
- Publication number
- CN112708660B CN112708660B CN201911017285.9A CN201911017285A CN112708660B CN 112708660 B CN112708660 B CN 112708660B CN 201911017285 A CN201911017285 A CN 201911017285A CN 112708660 B CN112708660 B CN 112708660B
- Authority
- CN
- China
- Prior art keywords
- crispr
- probe
- conjugate
- detection
- tracer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 80
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000012123 point-of-care testing Methods 0.000 title claims abstract description 30
- 239000000523 sample Substances 0.000 claims abstract description 73
- 238000012360 testing method Methods 0.000 claims abstract description 55
- 239000000700 radioactive tracer Substances 0.000 claims abstract description 42
- 238000003776 cleavage reaction Methods 0.000 claims abstract description 35
- 230000007017 scission Effects 0.000 claims abstract description 32
- 108091033409 CRISPR Proteins 0.000 claims abstract description 29
- 238000010354 CRISPR gene editing Methods 0.000 claims abstract description 28
- 230000005526 G1 to G0 transition Effects 0.000 claims abstract description 19
- 108020004414 DNA Proteins 0.000 claims abstract description 18
- 108090000790 Enzymes Proteins 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 14
- 238000003908 quality control method Methods 0.000 claims abstract description 13
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims abstract description 10
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 40
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 229960002685 biotin Drugs 0.000 claims description 21
- 239000011616 biotin Substances 0.000 claims description 21
- 235000020958 biotin Nutrition 0.000 claims description 20
- 239000011324 bead Substances 0.000 claims description 17
- 239000004005 microsphere Substances 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 230000008878 coupling Effects 0.000 claims description 10
- 238000010168 coupling process Methods 0.000 claims description 10
- 238000005859 coupling reaction Methods 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 239000000427 antigen Substances 0.000 claims description 8
- 102000036639 antigens Human genes 0.000 claims description 8
- 108091007433 antigens Proteins 0.000 claims description 8
- 102000053602 DNA Human genes 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims description 6
- 238000002372 labelling Methods 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 claims description 5
- 108010090804 Streptavidin Proteins 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 5
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 claims description 5
- 229960005156 digoxin Drugs 0.000 claims description 5
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 claims description 5
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 229920002401 polyacrylamide Polymers 0.000 claims description 2
- -1 polypropylene Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 238000003149 assay kit Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 238000007796 conventional method Methods 0.000 abstract description 2
- 108020004707 nucleic acids Proteins 0.000 description 12
- 102000039446 nucleic acids Human genes 0.000 description 12
- 150000007523 nucleic acids Chemical class 0.000 description 12
- 238000000137 annealing Methods 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 6
- 208000035473 Communicable disease Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000003317 immunochromatography Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920000620 organic polymer Polymers 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- MIIIXQJBDGSIKL-UHFFFAOYSA-N 2-morpholin-4-ylethanesulfonic acid;hydrate Chemical compound O.OS(=O)(=O)CCN1CCOCC1 MIIIXQJBDGSIKL-UHFFFAOYSA-N 0.000 description 2
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000193985 Streptococcus agalactiae Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000012113 quantitative test Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000907316 Zika virus Species 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- 239000002122 magnetic nanoparticle Substances 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911017285.9A CN112708660B (zh) | 2019-10-24 | 2019-10-24 | Crispr-poct检测组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911017285.9A CN112708660B (zh) | 2019-10-24 | 2019-10-24 | Crispr-poct检测组合物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112708660A CN112708660A (zh) | 2021-04-27 |
CN112708660B true CN112708660B (zh) | 2024-05-03 |
Family
ID=75540659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911017285.9A Active CN112708660B (zh) | 2019-10-24 | 2019-10-24 | Crispr-poct检测组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112708660B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111647642B (zh) * | 2020-05-19 | 2023-10-20 | 深圳市众循精准医学研究院 | 一种基于检测试纸显示的核酸检测方法及核酸检测试剂盒 |
CN113687066B (zh) * | 2021-09-16 | 2023-12-19 | 固安北吉生物科技有限公司 | 一种基于crispr系统的分子侧向层析检测方法及检测试纸条 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060099022A (ko) * | 2005-03-10 | 2006-09-19 | 김희태 | 멤브레인 측면 흐름 분석 기법을 사용하여 핵산서열을 검출및 분석하는 방법과 이의 킷트 |
JP2007189991A (ja) * | 2006-01-20 | 2007-08-02 | Nippon Meat Packers Inc | 遺伝子の検出方法 |
CN101215600A (zh) * | 2007-01-04 | 2008-07-09 | 中国科学院广州生物医药与健康研究院 | 核酸目的序列的检测探针及检测方法 |
US10253365B1 (en) * | 2017-11-22 | 2019-04-09 | The Regents Of The University Of California | Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs |
CN109825616A (zh) * | 2019-03-18 | 2019-05-31 | 广州微远基因科技有限公司 | 用于检测b族链球菌的引物组及其用途 |
CN110055352A (zh) * | 2019-02-26 | 2019-07-26 | 中国农业科学院农业质量标准与检测技术研究所 | 一种快速检测非洲猪瘟的试剂盒 |
CN110066865A (zh) * | 2019-04-30 | 2019-07-30 | 常州桐树生物科技有限公司 | 一种基于CRISPR-Cas13a的特异性核酸片段的检测方法及探针 |
CN110106290A (zh) * | 2019-05-31 | 2019-08-09 | 华南理工大学 | 一种基于CRISPR/Cas系统用于检测ASFV的现场快速检测方法及试剂盒 |
CN110184329A (zh) * | 2019-05-31 | 2019-08-30 | 华南理工大学 | 一种基于CRISPR/Cas和恒温扩增的一步法核酸检测方法和试剂盒 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016028843A2 (en) * | 2014-08-19 | 2016-02-25 | President And Fellows Of Harvard College | Rna-guided systems for probing and mapping of nucleic acids |
-
2019
- 2019-10-24 CN CN201911017285.9A patent/CN112708660B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060099022A (ko) * | 2005-03-10 | 2006-09-19 | 김희태 | 멤브레인 측면 흐름 분석 기법을 사용하여 핵산서열을 검출및 분석하는 방법과 이의 킷트 |
JP2007189991A (ja) * | 2006-01-20 | 2007-08-02 | Nippon Meat Packers Inc | 遺伝子の検出方法 |
CN101215600A (zh) * | 2007-01-04 | 2008-07-09 | 中国科学院广州生物医药与健康研究院 | 核酸目的序列的检测探针及检测方法 |
US10253365B1 (en) * | 2017-11-22 | 2019-04-09 | The Regents Of The University Of California | Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs |
CN110055352A (zh) * | 2019-02-26 | 2019-07-26 | 中国农业科学院农业质量标准与检测技术研究所 | 一种快速检测非洲猪瘟的试剂盒 |
CN109825616A (zh) * | 2019-03-18 | 2019-05-31 | 广州微远基因科技有限公司 | 用于检测b族链球菌的引物组及其用途 |
CN110066865A (zh) * | 2019-04-30 | 2019-07-30 | 常州桐树生物科技有限公司 | 一种基于CRISPR-Cas13a的特异性核酸片段的检测方法及探针 |
CN110106290A (zh) * | 2019-05-31 | 2019-08-09 | 华南理工大学 | 一种基于CRISPR/Cas系统用于检测ASFV的现场快速检测方法及试剂盒 |
CN110184329A (zh) * | 2019-05-31 | 2019-08-30 | 华南理工大学 | 一种基于CRISPR/Cas和恒温扩增的一步法核酸检测方法和试剂盒 |
Non-Patent Citations (3)
Title |
---|
CRISPR/Cas9在医学检验中的研究进展及应用;印晓静;《中华检验医学杂志》;20190805;第42卷(第5期);第381-385页 * |
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6;Jonathan S. Gootenberg;<Science>;第360卷(第6387期);第439-444页 * |
SHERLOCK: nucleic acid detection with CRISPR nucleases;Feng Zhang;《 nature protocols》;20190923;第14卷;第2986-3012页 * |
Also Published As
Publication number | Publication date |
---|---|
CN112708660A (zh) | 2021-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6795733B2 (ja) | コバインダー補助アッセイ法 | |
Tang et al. | Application of magnetic nanoparticles in nucleic acid detection | |
ES2424269T3 (es) | Inmuno-PCR sándwich por desplazamiento | |
JP5675782B2 (ja) | 標識化プローブ−水溶性担体複合体 | |
CN107607501A (zh) | 一种基于荧光淬灭的生物标志物多重检测方法 | |
ES2792873T3 (es) | Método para detectar molécula diana y kit para su uso en dicho método | |
CN107841527A (zh) | 一种利用核酸适配体和磁性材料检测凝血酶的荧光检测方法 | |
KR20130051647A (ko) | 자성 입자를 이용한 바이오 물질의 분석 방법 | |
CN112708660B (zh) | Crispr-poct检测组合物及其应用 | |
ES2636483T3 (es) | Métodos y sistemas para la amplificación de señal de bioensayos | |
Gao et al. | Rolling circle amplification integrated with suspension bead array for ultrasensitive multiplex immunodetection of tumor markers | |
CN113699148B (zh) | 一种超灵敏抗体检测方法 | |
CN112236527A (zh) | 通过连接共定位的夹心测定法 | |
AU679008B2 (en) | Mixed luminescent conjugate test assays | |
KR20200144498A (ko) | 핵산 검출 방법 | |
Alsohaimi | Analytical detection methods for diagnosis of COVID-19: developed methods and their performance | |
Xia et al. | Biosensors based on sandwich assays | |
EP3480320A1 (en) | Double-stranded nucleic acid signal probe and method for detecting target molecule using same | |
Anderson et al. | Amplification of microsphere-based microarrays using catalyzed reporter deposition | |
WO2004048975A1 (ja) | 黄色ブドウ球菌の検査方法 | |
CA2353920A1 (en) | Test system for detecting different markers, and production and use thereof | |
JP2022048030A (ja) | 標的核酸の検出方法およびキット | |
Si et al. | ELISA type fluorescence turn-on immunoassay based on Fe3+ induced fluorescence enhancement | |
US20230088664A1 (en) | Method of Detecting Analytes in a Sample | |
KR100723574B1 (ko) | 신규 프로브를 이용하여 돼지콜레라 바이러스 유전자를정량분석하는 방법 및 이의 시약 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230831 Address after: Room 301, G10, South China new material innovation park, building 3, No. 31, Kefeng Road, Guangzhou hi tech Industrial Development Zone, Guangdong 510130 Applicant after: Guangzhou Weiyuan Medical Equipment Co.,Ltd. Applicant after: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd. Applicant after: Guangzhou Weiyuan medical laboratory Co.,Ltd. Applicant after: Shenzhen Weiyuan Medical Technology Co.,Ltd. Address before: Room 301, G10, South China new material innovation park, building 3, No. 31, Kefeng Road, Guangzhou hi tech Industrial Development Zone, Guangdong 510130 Applicant before: Guangzhou Weiyuan Medical Equipment Co.,Ltd. Applicant before: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd. Applicant before: Guangzhou Weiyuan medical laboratory Co.,Ltd. Applicant before: Shenzhen Weiyuan Medical Technology Co.,Ltd. Applicant before: Weiyuan (Shenzhen) Medical Research Center Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |